CRISPR-GNDM holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 1 (Chemicals) with 1 filings. The WikiTrademarks Expansion Score is 5/100, low — the brand is focused on defending its existing categories rather than expanding.
USPTO data refreshed October 17, 2026
Protect or track "CRISPR-GNDM"
Watch this name and we'll alert you when anyone files a similar mark.
Informational only, not a legal opinion. Consult a trademark attorney before filing or enforcing.
Own this brand? Claim the profile to add your logo, story, and website.
Sign in to claimHow is CRISPR-GNDM filing trademarks, and where is the portfolio expanding?
Filing Velocity (24 Months)
Nice Class Distribution
Activity Timeline
No activity recorded yet.
Recent Filings
| Serial No. | Mark | Filing Date | Status | Classes | Owner |
|---|---|---|---|---|---|
| 79275387 | CRISPR-GNDM | Nov 15, 2019 | Pending | 001 Chemicals 005 Pharmaceuticals 042 Science & Technology 044 Medical & Beauty Services | Modalis Therapeutics Corporation |
Weekly visibility reports showing how ChatGPT mentions CRISPR-GNDM, where you rank in the answer, the sentiment of the mention, and which sources ChatGPT cites.
FAQ: CRISPR-GNDM trademark portfolio
What trademarks does CRISPR-GNDM hold?
CRISPR-GNDM holds 1 USPTO trademark filings across 0 NICE classes. The largest concentration is in Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Science & Technology). The most recent filings are registered to Modalis Therapeutics Corporation.
How many trademarks does CRISPR-GNDM have at the USPTO?
WikiTrademarks tracks 1 USPTO trademark filings attributed to CRISPR-GNDM. The brand has been actively filing since November 2019. The count updates daily as new filings are indexed from the USPTO bulk data feed.
In which NICE classes does CRISPR-GNDM file most often?
CRISPR-GNDM's most active class is NICE Class 1 (Chemicals), with 1 filings. The full distribution across all 0 classes is shown in the Nice Class Distribution panel on this page.
Who owns the CRISPR-GNDM trademark?
The most recent filings under the CRISPR-GNDM mark are registered to Modalis Therapeutics Corporation. Trademark ownership can shift through assignments — see the Ownership & Assignment History section on this page for the full chain of title.
Is CRISPR-GNDM expanding into new categories?
The current WikiTrademarks Expansion Score for CRISPR-GNDM is 5 out of 100, which is low — the brand is focused on defending its existing categories rather than expanding. The score combines NICE class breadth, filing velocity, and the rate of cross-class movement from the brand's filing history.
How can I track new CRISPR-GNDM trademark filings?
Click the Watch Brand button at the top of this page to add CRISPR-GNDM to your Watchlist. New filings show up on your WikiTrademarks dashboard within 24 to 48 hours of being public, alongside any class expansions, status changes, or assignment events.
More on this portfolio: Compare CRISPR-GNDM to another owner · Browse all NICE classes · Most valuable brands
Community notes
0 notesShare what you know about CRISPR-GNDM and help the next person researching it.